Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Multiple Myeloma Clinical Trial
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
CAH - Congenital Adrenal Hyperplasia Clinical Trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry: A Nested Study Within an Existing Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New Haven, CT
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jackson, MS
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Pensacola, FL
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Extension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Chemotherapy-Induced Thrombocytopenia Clinical Trial
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Commack, NY
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Epigenetic Reprogramming in Relapse/Refractory AML
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Omaha, NE
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Orange, CA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology Clinical Trial
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Amyloidogenic Transthyretin (ATTR) Amyloidosis Clinical Trial
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Porto,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Polycythemia Vera Clinical Trial
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Florham Park, NJ
Click here to add this to my saved trials
Relapsed/ Refractory Multiple Myeloma Clinical Trial
Study Evaluating AMG 424 in Subjects With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Charlotte, NC
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Harrison, NY
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
East Lansing, MI
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Caldwell, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Swansea, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tawas City, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Hematology, Other Clinical Trial
Post-Injury Platelet Biology: Mechanisms and Outcomes
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Augusta, GA
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Hyperglycemia, Exercise, and Endothelial Function
Status: Enrolling
Updated: 12/31/1969
mi
from
Iowa City, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bolivar, MO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Juan,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of APVO436 in Patients With AML or MDS
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of APVO436 in Patients With AML or MDS
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Westwood, KS
Click here to add this to my saved trials
Hematology Clinical Trial
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Gainesville, FL
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Westwood, KS
Click here to add this to my saved trials
Endocrinology, Hematology, Neurology, Oncology Clinical Trial
Registry for Adults With Plasma Cell Disorders (PCD's)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Augusta, GA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
East Lansing, MI
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Providence, RI
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Montvale, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Plantation, FL
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Austin, TX
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acute Myeloid Leukemia (AML) Clinical Trial
A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Caba,
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Monticello, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Ontario, OR
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Relapsed and/or Refractory Multiple Myeloma Clinical Trial
Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Louisville, KY
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Decatur, IL
Click here to add this to my saved trials
Hemophilia Clinical Trial
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Camden, NJ
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New Orleans, LA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Omaha, NE
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Colchester, VT
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Ocean City, NJ
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Peabody, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Commack, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials